Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Werewolf Therapeutics, Inc. - Common Stock
(NQ:
HOWL
)
0.7230
+0.0034 (+0.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Werewolf Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Werewolf Therapeutics to Present at the Jefferies Healthcare Conference
June 01, 2023
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Expert Ratings for Werewolf Therapeutics
↗
May 11, 2023
Via
Benzinga
Recap: Werewolf Therapeutics Q1 Earnings
↗
May 11, 2023
Via
Benzinga
Werewolf Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
May 11, 2023
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Werewolf Therapeutics to Participate in May Investor Conferences
May 01, 2023
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Analyst Ratings for Werewolf Therapeutics
↗
March 24, 2023
Via
Benzinga
Werewolf Therapeutics Publishes Preclinical Data on mWTX-330, an IL-12 INDUKINE™ Molecule, in Cancer Immunology Research
April 19, 2023
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 23, 2023
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
UPDATE -- Werewolf Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2023
March 16, 2023
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Werewolf Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2023
March 15, 2023
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Werewolf Therapeutics Announces Initiation of Patient Dosing in Phase 1 Study of WTX-330
February 24, 2023
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Werewolf Therapeutics to Present at the SVB Securities Global Biopharma Conference
February 07, 2023
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
January 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
January 13, 2023
Via
Benzinga
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
January 12, 2023
Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company announced it has been awarded a multiple award $900 million Indefinite Delivery/Indefinite Quantity...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
January 11, 2023
Via
Benzinga
Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
January 11, 2023
Gainers Broadwind Inc (NASDAQ: BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine...
Via
Benzinga
Over $4 Million Bet On Werewolf Therapeutics? Check Out These 4 Penny Stocks Insiders Are Buying
↗
January 11, 2023
The Dow Jones closed higher on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
January 11, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022
↗
December 05, 2022
Via
Benzinga
Werewolf Therapeutics Presents Preclinical Data on mWTX-330, a Surrogate IL-12 INDUKINE™ Molecule, at the Society for Immunotherapy of Cancer Annual Meeting
November 10, 2022
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Werewolf Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
November 10, 2022
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Werewolf Therapeutics to Present Preclinical Data at Society for Immunotherapy of Cancer Annual Meeting and Participate in Upcoming Investor Conferences
November 07, 2022
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
↗
September 01, 2022
Via
Benzinga
Werewolf Shares Climb As Initial-Stage Solid Tumors Study Kicks-off
↗
September 01, 2022
Werewolf Therapeutics (NASDAQ: HOWL) has initiated patient dosing in a Phase 1/1b clinical trial evaluating WTX-124, its lead INDUKINET molecule targeting IL-2 for the treatment of solid tumors.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
October 27, 2022
On Thursday, 111 stocks hit new 52-week lows.
Via
Benzinga
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
↗
September 06, 2022
Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
↗
August 29, 2022
What are Value Stocks?
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
June 28, 2022
Gainers
Via
Benzinga
Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday
↗
September 02, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
